Best Practice & Research Clinical Anaesthesiology
Volume 24, Issue 1 , Pages 1-14 , March 2010

Principles of perioperative coagulopathy

  • Petra Innerhofer, MD (Assoc. Prof.)

      Affiliations

    • Department of Anaesthesiology and Critical Care Medicine, Innsbruck Medical University, Anichstrasse 35, A-6020 Innsbruck, Austria
    • Corresponding Author InformationCorresponding author. Tel.: +43 512 504 80407.
    • ,
  • Joachim Kienast, MD (Assoc. Prof.)

      Affiliations

    • Department of Internal Medicine, University of Muenster, Albert Schweitzerstrasse 33, D-48149 Muenster, Germany

References 

  1. Blumberg N. Deleterious clinical effects of transfusion immunomodulation: proven beyond a reasonable doubt. Transfusion. 2005;45:33S–39Sdiscussion 39S–40S
  2. Clark DA, Gorczynski RM, Blajchman MA. Transfusion-related immunomodulation due to peripheral blood dendritic cells expressing the CD200 tolerance signaling molecule and alloantigen. Transfusion. 2008;48:814–821
  3. Dunne JR, Lee TH, Burns C, et al. Transfusion-associated microchimerism in combat casualties. The Journal of Trauma. 2008;64:S92–S97discussion S97–98
  4. Gajic O, Gropper MA, Hubmayr RD. Pulmonary edema after transfusion: how to differentiate transfusion-associated circulatory overload from transfusion-related acute lung injury. Critical Care Medicine. 2006;34:S109–S113
  5. Adams GL, Manson RJ, Turner I, et al. The balance of thrombosis and hemorrhage in surgery. Hematology/Oncology Clinics of North America. 2007;21:13–24
  6. Koscielny J, Ziemer S, Radtke H, et al. A practical concept for preoperative identification of patients with impaired primary hemostasis. Clinical and Applied Thrombosis/Hemostasis. 2004;10:195–204
  7. Knofler R, Olivieri M, Weickardt S, et al. First results of the THROMKID study: a quality project for the registration of children und adolescents with hereditary platelet function defects in Germany, Austria, and Switzerland, Hamostaseologie. 2007;27:48–53
  8. Schneppenheim R, Budde U. Inborn and acquired von Willebrand disease, Hamostaseologie. 2008;28:312–319
  9. Pfanner G, Koscielny J, Pernerstorfer T, et al. Preoperative evaluation of the bleeding history. Recommendations of the working group on perioperative coagulation of the Austrian Society for Anaesthesia, Resuscitation and Intensive Care, Der Anaesthesist. 2007;56:604–611
  10. Liu N, Kessler C. In:  Kitchens CS,  Alving B,  Kessler C editor. A systemic approach to the bleeding patient. Philadelphia: W.B. Saunders; 2002;
  11. Budde U, Bergmann F, Michiels JJ. Acquired von Willebrand syndrome: experience from 2 years in a single laboratory compared with data from the literature and an international registry. Seminars in Thrombosis and Hemostasis. 2002;28:227–238
  12. Velik-Salchner C, Eschertzhuber S, Streif W, et al. Acquired von Willebrand syndrome in cardiac patients. Journal of Cardiothoracic and Vascular Anesthesia. 2008;22:719–724
  13. Dzik WH. Predicting hemorrhage using preoperative coagulation screening assays. Current Hematology Reports. 2004;3:324–330
  14. Kitchens CS. To bleed or not to bleed? Is that the question for the PTT?. Journal of Thrombosis and Haemostasis. 2005;3:2607–2611
  15. Peyvandi F, Cattaneo M, Inbal A, et al. Rare bleeding disorders. Haemophilia. 2008;14(Suppl. 3):202–210
  16. Li J, Shen H, Hou T, et al. Acquired hemophilia a in a patient with lumbar disc herniation: a case report and review of the literature. Spine. 2009;34:E305–E308
  17. Singbartl K, Innerhofer P, Radvan J, et al. Hemostasis and hemodilution: a quantitative mathematical guide for clinical practice. Anesthesia and Analgesia. 2003;96:929–935table of contents
  18. Hoffman M. A cell-based model of coagulation and the role of factor VIIa. Blood Reviews. 2003;17(Suppl. 1):S1–S5
  19. Rivard GE, Brummel-Ziedins KE, Mann KG, et al. Evaluation of the profile of thrombin generation during the process of whole blood clotting as assessed by thrombelastography. Journal of Thrombosis and Haemostasis. 2005;3:2039–2043
  20. Ni H, Denis CV, Subbarao S, et al. Persistence of platelet thrombus formation in arterioles of mice lacking both von Willebrand factor and fibrinogen. The Journal of Clinical Investigation. 2000;106:385–392
  21. Rojkjaer LP, Rojkjaer R. Clot stabilization for the prevention of bleeding. Hematology/Oncology Clinics of North America. 2007;21:25–32
  22. Mosesson MW. Update on antithrombin I (fibrin). Thrombosis and Haemostasis. 2007;98:105–108
  23. Tanaka KA, Taketomi T, Szlam F, et al. Improved clot formation by combined administration of activated factor VII (NovoSeven) and fibrinogen (Haemocomplettan P). Anesthesia and Analgesia. 2008;106:732–738table of contents
  24. Lewis NR, Brunker P, Lemire SJ, et al. Failure of recombinant factor VIIa to correct the coagulopathy in a case of severe postpartum hemorrhage. Transfusion. 2009;49:689–695
  25. Collins PW, Macchiavello LI, Lewis SJ, et al. Global tests of haemostasis in critically ill patients with severe sepsis syndrome compared to controls. British Journal of Haematology. 2006;135:220–227
  26. Velik-Salchner C, Maier S, Innerhofer P, et al. An assessment of cardiopulmonary bypass-induced changes in platelet function using whole blood and classical light transmission aggregometry: the results of a pilot study. Anesthesia and Analgesia. 2009;108:1747–1754
  27. Mannucci PM, Federici AB, Sirchia G. Hemostasis testing during massive blood replacement. A study of 172 cases. Vox Sanguinis. 1982;42:113–123
  28. Ciavarella D, Reed RL, Counts RB, et al. Clotting factor levels and the risk of diffuse microvascular bleeding in the massively transfused patient. British Journal of Haematology. 1987;67:365–368
  29. Martini WZ, Chinkes DL, Pusateri AE, et al. Acute changes in fibrinogen metabolism and coagulation after hemorrhage in pigs. American Journal of Physiology. Endocrinology and Metabolism. 2005;289:E930–E934
  30. Hiippala ST, Myllyla GJ, Vahtera EM. Hemostatic factors and replacement of major blood loss with plasma-poor red cell concentrates. Anesthesia and Analgesia. 1995;81:360–365
  31. McLoughlin TM, Fontana JL, Alving B, et al. Profound normovolemic hemodilution: hemostatic effects in patients and in a porcine model. Anesthesia and Analgesia. 1996;83:459–465
  32. Practice Guidelines for blood component therapy: A report by the American Society of Anesthesiologists Task Force on Blood Component Therapy. Anesthesiology. 1996;84:732–747
  33. Stainsby D, MacLennan S, Thomas D, et al. Guidelines on the management of massive blood loss. British Journal of Haematology. 2006;135:634–641
  34. Nielsen VG, Cohen BM, Cohen E. Effects of coagulation factor deficiency on plasma coagulation kinetics determined via thrombelastography: critical roles of fibrinogen and factors II, VII, X and XII. Acta Anaesthesiologica Scandinavica. 2005;49:222–231
  35. Gerlach R, Tolle F, Raabe A, et al. Increased risk for postoperative hemorrhage after intracranial surgery in patients with decreased factor XIII activity: implications of a prospective study. Stroke. 2002;33:1618–1623
  36. Blome M, Isgro F, Kiessling AH, et al. Relationship between factor XIII activity, fibrinogen, haemostasis screening tests and postoperative bleeding in cardiopulmonary bypass surgery. Thrombosis and Haemostasis. 2005;93:1101–1107
  37. Karlsson M, Ternstrom L, Hyllner M, et al. Plasma fibrinogen level, bleeding, and transfusion after on-pump coronary artery bypass grafting surgery: a prospective observational study. Transfusion. 2008;48:2152–2158
  38. Charbit B, Mandelbrot L, Samain E, et al. The decrease of fibrinogen is an early predictor of the severity of postpartum hemorrhage. Journal of Thrombosis and Haemostasis. 2007;5:266–273
  39. Bolliger D, Szlam F, Molinaro RJ, et al. Finding the optimal concentration range for fibrinogen replacement after severe haemodilution: an in vitro model. British Journal of Anaesthesia. 2009;102:793–799
  40. Weinstock N, Ntefidou M. SSC International Collaborative Study to establish the first high fibrinogen plasma reference material for use with different fibrinogen assay techniques. Journal of Thrombosis and Haemostasis. 2006;4:1825–1827
  41. Hiippala ST. Dextran and hydroxyethyl starch interfere with fibrinogen assays. Blood Coagulation & Fibrinolysis. 1995;6:743–746
  42. Mittermayr M, Streif W, Haas T, et al. Hemostatic changes after crystalloid or colloid fluid administration during major orthopedic surgery: the role of fibrinogen administration. Anesthesia and Analgesia. 2007;105:905–917table of contents
  43. Innerhofer P. Perioperative management of coagulation, Hamostaseologie. 2006;26:S3–14
  44. Huissoud C, Carrabin N, Audibert F, et al. Bedside assessment of fibrinogen level in postpartum haemorrhage by thrombelastometry. BJOG : An International Journal of Obstetrics and Gynaecology. 2009;116:1097–1102
  45. Velik-Salchner C, Haas T, Innerhofer P, et al. The effect of fibrinogen concentrate on thrombocytopenia. Journal of Thrombosis and Haemostasis. 2007;5:1019–1025
  46. Lang T, Johanning K, Metzler H, et al. The effects of fibrinogen levels on thromboelastometric variables in the presence of thrombocytopenia. Anesthesia and Analgesia. 2009;108:751–758
  47. Al Dieri R, Peyvandi F, Santagostino E, et al. The thrombogram in rare inherited coagulation disorders: its relation to clinical bleeding. Thrombosis and Haemostasis. 2002;88:576–582
  48. Allen GA, Wolberg AS, Oliver JA, et al. Impact of procoagulant concentration on rate, peak and total thrombin generation in a model system. Journal of Thrombosis and Haemostasis. 2004;2:402–413
  49. Davidson SJ, Burman JF, Philips SM, et al. Correlation between thrombin potential and bleeding after cardiac surgery in adults. Blood Coagulation & Fibrinolysis. 2003;14:175–179
  50. Schols SE, van der Meijden PE, van Oerle R, et al. Increased thrombin generation and fibrinogen level after therapeutic plasma transfusion: relation to bleeding. Thrombosis and Haemostasis. 2008;99:64–70
  51. Monroe DM. Modeling the action of factor VIIa in dilutional coagulopathy. Thrombosis Research. 2008;122(Suppl. 1):S7–S10
  52. Horne MK, Merryman PK, Cullinane AM, et al. The impact of major surgery on blood coagulation factors and thrombin generation. American Journal of Hematology. 2007;82:815–820
  53. Burns ER, Goldberg SN, Wenz B. Paradoxic effect of multiple mild coagulation factor deficiencies on the prothrombin time and activated partial thromboplastin time. American Journal of Clinical Pathology. 1993;100:94–98
  54. Chandler WL, Patel MA, Gravelle L, et al. Factor XIIIA and clot strength after cardiopulmonary bypass. Blood Coagulation & Fibrinolysis. 2001;12:101–108
  55. Wettstein P, Haeberli A, Stutz M, et al. Decreased factor XIII availability for thrombin and early loss of clot firmness in patients with unexplained intraoperative bleeding. Anesthesia and Analgesia. 2004;99:1564–1569table of contents
  56. Nielsen VG, Gurley WQ, Burch TM. The impact of factor XIII on coagulation kinetics and clot strength determined by thrombelastography. Anesthesia and Analgesia. 2004;99:120–123
  57. Brummel-Ziedins KE, Pouliot RL, Mann KG. Thrombin generation: phenotypic quantitation. Journal of Thrombosis and Haemostasis. 2004;2:281–288
  58. Maegele M. Frequency, risk stratification and therapeutic management of acute post-traumatic coagulopathy. Vox Sanguinis. 2009;97:39–49
  59. de Jonge E, Levi M. Effects of different plasma substitutes on blood coagulation: a comparative review. Critical Care Medicine. 2001;29:1261–1267
  60. Niemi TT, Kuitunen AH. Artificial colloids impair haemostasis. An in vitro study using thromboelastometry coagulation analysis. Acta Anaesthesiologica Scandinavica. 2005;49:373–378
  61. Innerhofer P, Fries D, Margreiter J, et al. The effects of perioperatively administered colloids and crystalloids on primary platelet-mediated hemostasis and clot formation. Anesthesia and Analgesia. 2002;95:858–865table of contents
  62. Kozek-Langenecker SA. Effects of hydroxyethyl starch solutions on hemostasis. Anesthesiology. 2005;103:654–660
  63. Fries D, Innerhofer P, Klingler A, et al. The effect of the combined administration of colloids and lactated Ringer's solution on the coagulation system: an in vitro study using thrombelastograph coagulation analysis (ROTEG). Anesth Analg. 2002;94:1280–1287
  64. Madjdpour C, Dettori N, Frascarolo P, et al. Molecular weight of hydroxyethyl starch: is there an effect on blood coagulation and pharmacokinetics?. British Journal of Anaesthesia. 2005;94:569–576
  65. Treib J, Baron JF, Grauer MT, et al. An international view of hydroxyethyl starches. Intensive Care Medicine. 1999;25:258–268
  66. de Jonge E, Levi M, Berends F, et al. Impaired haemostasis by intravenous administration of a gelatin-based plasma expander in human subjects. Thrombosis and Haemostasis. 1998;79:286–290
  67. Chappell D, Bruchelt W, Schenk W, et al. Development of spontaneous subdural hematoma and bone marrow depression after hydroxyethyl starch administration. The Journal of Pediatrics. 2008;153:579–581
  68. Fries D, Streif W, Margreiter J, et al. The effects of perioperatively administered crystalloids and colloids on concentrations of molecular markers of activated coagulation and fibrinolysis. Blood Coagulation & Fibrinolysis. 2004;15:213–219
  69. Mittermayr M, Streif W, Haas T, et al. Effects of colloid and crystalloid solutions on endogenous activation of fibrinolysis and resistance of polymerized fibrin to recombinant tissue plasminogen activator added ex vivo. British Journal of Anaesthesia. 2008;100:307–314
  70. Nielsen VG. Hemodilution modulates the time of onset and rate of fibrinolysis in human and rabbit plasma. The Journal of Heart and Lung Transplantation. 2006;25:1344–1352
  71. Nielsen VG. Colloids decrease clot propagation and strength: role of factor XIII-fibrin polymer and thrombin-fibrinogen interactions. Acta Anaesthesiologica Scandinavica. 2005;49:1163–1171
  72. Ruttmann TG. Haemodilution enhances coagulation. British Journal of Anaesthesia. 2002;88:470–472
  73. Brummel-Ziedins K, Whelihan MF, Ziedins EG, et al. The resuscitative fluid you choose may potentiate bleeding. The Journal of Trauma. 2006;61:1350–1358
  74. Kiraly LN, Differding JA, Enomoto TM, et al. Resuscitation with normal saline (NS) vs. lactated ringers (LR) modulates hypercoagulability and leads to increased blood loss in an uncontrolled hemorrhagic shock swine model. The Journal of Trauma. 2006;61:57–64discussion 64–55
  75. Haas T, Fries D, Holz C, et al. Less impairment of hemostasis and reduced blood loss in pigs after resuscitation from hemorrhagic shock using the small-volume concept with hypertonic saline/hydroxyethyl starch as compared to administration of 4% gelatin or 6% hydroxyethyl starch solution. Anesthesia and Analgesia. 2008;106:1078–1086table of contents
  76. Haas T, Fries D, Velik-Salchner C, et al. The in vitro effects of fibrinogen concentrate, factor XIII and fresh frozen plasma on impaired clot formation after 60% dilution. Anesthesia and Analgesia. 2008;106:1360–1365table of contents
  77. Fenger-Eriksen C, Tonnesen E, Ingerslev J, et al. Mechanisms of hydroxyethyl starch induced dilutional coagulopathy. Journal of Thrombosis and Haemostasis. 2009;7:1099–1105
  78. De Lorenzo C, Calatzis A, Welsch U, et al. Fibrinogen concentrate reverses dilutional coagulopathy induced in vitro by saline but not by hydroxyethyl starch 6%. Anesthesia and Analgesia. 2006;102:1194–1200
  79. Hardy JF, De Moerloose P, Samama M. Massive transfusion and coagulopathy: pathophysiology and implications for clinical management. Canadian Journal of Anaesthesia. 2004;51:293–310
  80. Lier H, Krep H, Schroeder S, et al. Preconditions of hemostasis in trauma: a review. The influence of acidosis, hypocalcemia, anemia, and hypothermia on functional hemostasis in trauma. The Journal of Trauma. 2008;65:951–960
  81. Martini WZ. The effects of hypothermia on fibrinogen metabolism and coagulation function in swine. Metabolism. 2007;56:214–221
  82. Meng ZH, Wolberg AS, Monroe DM, et al. The effect of temperature and pH on the activity of factor VIIa: implications for the efficacy of high-dose factor VIIa in hypothermic and acidotic patients. The Journal of Trauma. 2003;55:886–891
  83. Michelson AD, MacGregor H, Barnard MR, et al. Reversible inhibition of human platelet activation by hypothermia in vivo and in vitro. Thrombosis and Haemostasis. 1994;71:633–640
  84. Faraday N, Rosenfeld BA. In vitro hypothermia enhances platelet GPIIb-IIIa activation and P-selectin expression. Anesthesiology. 1998;88:1579–1585
  85. Martini WZ, Dubick MA, Pusateri AE, et al. Does bicarbonate correct coagulation function impaired by acidosis in swine?. The Journal of Trauma. 2006;61:99–106

PII: S1521-6896(09)00070-6

doi: 10.1016/j.bpa.2009.09.006

Best Practice & Research Clinical Anaesthesiology
Volume 24, Issue 1 , Pages 1-14 , March 2010

Article Tools

* Image Usage & Resolution